JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99963

Anti-FOXP3 antibody [SP97]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

3

(3 Reviews)

|

(38 Publications )

Anti-FOXP3 antibody [SP97] (ab99963) is a rabbit monoclonal antibody detecting FOXP3 in IHC-P. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
- Trusted since 2010
14 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling FOXP3 with ab99963, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on a subset of T cells in the human tonsil. The section was incubated with ab99963 for 30 mins at room temperature. Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human cervical squamous cell carcinoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Immunohistochemical analysis of Human Tonsil tissue labelling FOXP3 with ab99963.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human bladder transitional cell carcinoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human stomach adenocarcinoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human pancreatic adenocarcinoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human B cell lymphoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human bladder tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human colon tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human colon adenocarcinoma tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human thymus tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Formalin-fixed, paraffin-embedded human lymph node tissue stained for FOXP3 using ab99963 at 1/100 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Immunohistochemical analysis of formalin fixed paraffin embedded human spleen labelling FOXP3 with ab99963 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab99963 Anti-FOXP3 antibody [SP97] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control. Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [SP97] (AB99963)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling FOXP3 with ab99963 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab99963 Anti-FOXP3 antibody [SP97] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control. Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

SP97

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p>Boil tissue section in 10mM Citrate, pH 6.0 for 10 min followed by cooling at RT for 20 min.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p>Boil tissue section in 10mM Citrate, pH 6.0 for 10 min followed by cooling at RT for 20 min.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p>Boil tissue section in 10mM Citrate, pH 6.0 for 10 min followed by cooling at RT for 20 min.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Cow": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Dog": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Pig": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-FOXP3 antibody [SP97] (ab99963) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples.

Collaboration
Anti-FOXP3 [SP97] (ab99963) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).

Trusted by the scientific community
Anti-FOXP3 [SP97] (ab99963) was first used in a scientific publication in 2010 and has been cited over 20 times in peer-reviewed journals.

Other related products
We have a range of other formats of antibody clone [SP97] also available for your convenience: ab99963, Carrier free - ab238809, Alexa Fluor® 647 - ab275079, Alexa Fluor® 594 - ab275080, Alexa Fluor® 488 - ab275119, Alexa Fluor® 555 - ab275120, ab279525, Carrier free - ab302838

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXP3 also recognized as Forkhead box P3 is a transcription factor critical for immune system function. It weighs approximately 47 kDa. FOXP3 is mainly expressed in regulatory T cells (Tregs) which play a role in maintaining immune tolerance. Scientists primarily identify its presence in the nucleus where it facilitates transcriptional regulation. Methods like 'FOXP3 IHC' and 'FOXP3 IHC mouse' are useful for detecting this protein in tissue samples while 'FOXP3 antibodies' aid in research on this target. Techniques like 'FOXP3 staining' and 'FOXP3 flow cytometry' further allow for the analysis of its expression and function.
Biological function summary

This transcription factor operates by regulating the expression of a variety of genes involved in Treg cell development and function. FOXP3 can interact with other proteins to form complexes that modulate gene expression. Its role is essential in enabling Tregs to suppress immune responses a process necessary for preventing autoimmunity. The interaction extends to other key regulators within Tregs such as the protein complex 221D which may have overlapping functional responsibilities. 'FOXP3 236a/E7' reflects its genetic variants detectable in different studies providing insights into its biological functions.

Pathways

FOXP3 is a significant player within the immune regulation pathway. It integrates into the TGF-beta signaling pathway in which it controls the expression of genes important for Treg functions. The protein recruits other transcription factors like NF-kB coordinating intricate network regulations within immune cells. FOXP3's activity orchestrates the balance between immune activation and suppression ensuring a well-functioning immune response that prevents overreactions leading to autoimmune conditions.

FOXP3 mutations or dysregulation can link to autoimmune diseases like immune dysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX). This transcription factor's malfunction implicates cancer where inadequate Treg function can either suppress antitumor immunity or result in tumor progression. Proteins such as CTLA-4 which is also involved in immune regulation connect to FOXP3 in these contexts emphasizing FOXP3's significant role in maintaining immune homeostasis and its impact on disease development.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg) (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479, PubMed : 24835996, PubMed : 30513302, PubMed : 32644293). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells (PubMed : 23169781). Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479). The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG) (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479). Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2 (PubMed : 15790681). Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7 (PubMed : 17360565). Can activate the expression of TNFRSF18, IL2RA and CTLA4 and repress the expression of IL2 and IFNG via its association with transcription factor RUNX1 (PubMed : 17377532). Inhibits the differentiation of IL17 producing helper T-cells (Th17) by antagonizing RORC function, leading to down-regulation of IL17 expression, favoring Treg development (PubMed : 18368049). Inhibits the transcriptional activator activity of RORA (PubMed : 18354202). Can repress the expression of IL2 and IFNG via its association with transcription factor IKZF4 (By similarity).
See full target information FOXP3

Alternative Names

IPEX, JM2, FOXP3, Forkhead box protein P3, Scurfin

Publications (38)

Recent publications for all applications. Explore the full listand refine your search

Nature communications 16:8673 PubMed41027867

2025

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Dominic Schmid,Bettina Sobottka,Massimiliano Manzo,Marta Trüb,Katharina Leonards,Petra Herzig,Oluwaseun Rume-Abiola Oyewole,Philip Jermann,Stefanie Hayoz,Spasenija Savic Prince,Giulia Tochtermann,Marina Natoli,Miklos Pless,Adrienne Bettini,Martin Früh,Laetitia A Mauti,Christian Britschgi,Solange Peters,Michael Mark,Adrian F Ochsenbein,Wolf-Dieter Janthur,Christine Waibel,Nicolas Mach,Patrizia Froesch,Martin Buess,Pierre Bohanes,Michel Gonzalez,Ilaria Alborelli,Sacha I Rothschild,Viktor Hendrik Koelzer,Alfred Zippelius

World journal of surgical oncology 23:329 PubMed40883713

2025

The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes.

Applications

Unspecified application

Species

Unspecified reactive species

Rirong Qu,Yang Zhang,Shenghui Qin,Jing Xiong,Xiangning Fu,Shaojie Hu,Yixin Cai

JCO precision oncology 9:e2500404 PubMed40749151

2025

Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Applications

Unspecified application

Species

Unspecified reactive species

Denise M Connolly,Gabriel Revon-Rivière,Rose Chami,Denise Mills,Ailish C Coblentz,Thomas S Uldrick,David A Knorr,Priscila Goncalves,Michael Dobosz,Sumreen Jalal,Sarah Cohen-Gogo,Daniel A Morgenstern

Nature communications 16:5588 PubMed40593647

2025

Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies.

Applications

Unspecified application

Species

Unspecified reactive species

Isabelle Damei,Aziza Caidi,Edouard Auclin,Julien Adam,Sébastien Mella,Milena Hasan,Eric Tartour,Caroline Robert,Stéphanie Corgnac,Fathia Mami-Chouaib

Discover oncology 16:427 PubMed40158055

2025

Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zachary A Cooper,Ying Wang,Philip L Martin,Kosho Murayama,Rakesh Kumar,Ken Kato,Shun Yamamoto,Shigeki Sekine

Nature 637:1218-1227 PubMed39663448

2024

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Applications

Unspecified application

Species

Unspecified reactive species

Ignacio Melero,Maria de Miguel Luken,Guillermo de Velasco,Elena Garralda,Juan Martín-Liberal,Markus Joerger,Guzman Alonso,Maria-Elisabeth Goebeler,Martin Schuler,David König,Reinhard Dummer,Maria Reig,Maria-Esperanza Rodriguez Ruiz,Emiliano Calvo,Jorge Esteban-Villarrubia,Arjun Oberoi,Paula Sabat,Juan José Soto-Castillo,Kira-Lee Koster,Omar Saavedra,Cyrus Sayehli,Tanja Gromke,Heinz Läubli,Egle Ramelyte,Marta Fortuny,Ana Landa-Magdalena,Irene Moreno,Javier Torres-Jiménez,Alberto Hernando-Calvo,Dagmar Hess,Fabricio Racca,Heike Richly,Andreas M Schmitt,Corinne Eggenschwiler,Marco Sanduzzi-Zamparelli,Anna Vilalta-Lacarra,Jörg Trojan,Christine Koch,Peter R Galle,Friedrich Foerster,Zlatko Trajanoski,Hubert Hackl,Falk Gogolla,Florestan J Koll,Peter Wild,Felix Kyoung Hwan Chun,Henning Reis,Peter Lloyd,Matthias Machacek,Thomas F Gajewski,Wolf H Fridman,Alexander M M Eggermont,Ralf Bargou,Sandra Schöniger,Josef Rüschoff,Anastasiia Tereshchenko,Carina Zink,Antonio da Silva,Felix S Lichtenegger,Julia Akdemir,Manfred Rüdiger,Phil L'Huillier,Aradhana Dutta,Markus Haake,Alexandra Auckenthaler,Ana Gjorgjioska,Bernhard Rössler,Frank Hermann,Mara Liebig,Daniela Reichhardt,Christine Schuberth-Wagner,Jörg Wischhusen,Petra Fettes,Marlene Auer,Kathrin Klar,Eugen Leo

The Kurume medical journal 70:145-155 PubMed39218645

2024

Cell Type-Specific Relationships Among Immune Cells in Human Aortic Dissection Tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Shinya Negoto,Hiroki Aoki,Koichi Ohshima,Eiji Nakamura,Takahiro Shojima,Kazuyoshi Takagi,Hiroyuki Otsuka,Tohru Takaseya,Shinichi Hiromatsu,Eiki Tayama

Nature biotechnology 43:323-328 PubMed38714897

2024

Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

Applications

Unspecified application

Species

Unspecified reactive species

Rémy Pétremand,Johanna Chiffelle,Sara Bobisse,Marta A S Perez,Julien Schmidt,Marion Arnaud,David Barras,Maria Lozano-Rabella,Raphael Genolet,Christophe Sauvage,Damien Saugy,Alexandra Michel,Anne-Laure Huguenin-Bergenat,Charlotte Capt,Jonathan S Moore,Claudio De Vito,S Intidhar Labidi-Galy,Lana E Kandalaft,Denarda Dangaj Laniti,Michal Bassani-Sternberg,Giacomo Oliveira,Catherine J Wu,George Coukos,Vincent Zoete,Alexandre Harari

Nature 627:646-655 PubMed38418879

2024

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangnan Guan,Ruozhen Hu,Yoonha Choi,Shyam Srivats,Barzin Y Nabet,John Silva,Lisa McGinnis,Robert Hendricks,Katherine Nutsch,Karl L Banta,Ellen Duong,Alexis Dunkle,Patrick S Chang,Chia-Jung Han,Stephanie Mittman,Nandini Molden,Pallavi Daggumati,Wendy Connolly,Melissa Johnson,Delvys Rodriguez Abreu,Byoung Chul Cho,Antoine Italiano,Ignacio Gil-Bazo,Enriqueta Felip,Ira Mellman,Sanjeev Mariathasan,David S Shames,Raymond Meng,Eugene Y Chiang,Robert J Johnston,Namrata S Patil

Cancers 15: PubMed37509274

2023

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Susana Cedres,Garazi Serna,Alberto Gonzalez-Medina,Augusto Valdivia,Juan David Assaf-Pastrana,Patricia Iranzo,Ana Callejo,Nuria Pardo,Alejandro Navarro,Alex Martinez-Marti,Ilaria Priano,Roberta Fasani,Xavier Guardia,Javier Gonzalo,Caterina Carbonell,Joan Frigola,Ramon Amat,Victor Navarro,Rodrigo Dienstmann,Ana Vivancos,Paolo Nuciforo,Enriqueta Felip
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com